カテゴリー： Stratistics MRC, 世界, 医療/バイオ

低分子創薬のグローバル市場（～2027）：腫瘍、中枢神経系、心臓血管、呼吸器、代謝障害、胃腸、その他

◆英語タイトル：Small Molecule Drug Discovery Market Forecasts to 2028 – Global Analysis By Therapeutic Area(Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal and Other Therapeutic Areas), Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization), End User (Pharmaceutical & biotechnology companies and Academic Institutes) and By Geography

Stratistics MRCが発行した調査報告書（SMR23MR016）◆商品コード：SMR23MR016
◆発行会社（リサーチ会社）：Stratistics MRC
◆発行日：2022年9月
◆ページ数：約150
◆レポート形式：英語 / Eメール
◆納品方法：英語
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Global Site LicenseUSD4,150 ⇒換算￥630,800見積依頼/購入/質問フォーム
PDFUSD7,500 ⇒換算￥1,140,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）

❖ レポートの概要 ❖

Stratistics MRC社の本調査レポートでは、世界の低分子創薬市場規模が2022年に34621.82百万ドルから2028年には66527.18百万ドルに上り、予測期間中にCAGR 11.5%で成長すると展望しています。本書では、低分子創薬の世界市場について徹底的に調査・分析を行い、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、治療別（腫瘍、中枢神経系、心臓血管、呼吸器、代謝障害、胃腸、その他）分析、プロセス/フェーズ別（ターゲットID/検証、ヒット生成＆選択、識別＆リード最適化）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、学術機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、最近の動向、企業情報などを考察しています。また、21st Century Therapeutics Inc., Gilead Sciences Inc., BioNTech (4SC-Discovery ), Bristol-Myers Squibb Company, Acacia Pharma Gr, AstraZeneca, Agilent Technologies Inc., Boehringer Ingelheim GmbHなどの企業情報を収録しています。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の低分子創薬市場規模：治療別
- 腫瘍における市場規模
- 中枢神経系における市場規模
- 心臓血管における市場規模
- 呼吸器における市場規模
- その他治療における市場規模
・世界の低分子創薬市場規模：プロセス/フェーズ別
- ターゲットID/検証の市場規模
- ヒット生成＆選択の市場規模
- 識別＆リード最適化の市場規模
・世界の低分子創薬市場規模：エンドユーザー別
- 製薬＆バイオテクノロジー企業における市場規模
- 学術機関における市場規模
・世界の低分子創薬市場規模：地域別
- 北米の低分子創薬市場規模
- ヨーロッパの低分子創薬市場規模
- アジア太平洋の低分子創薬市場規模
- 南米の低分子創薬市場規模
- 中東・アフリカの低分子創薬市場規模
・最近の動向
・企業情報

According to Stratistics MRC, the Global Small Molecule Drug Discovery Market is accounted for $ 34621.82 million 2022 and is expected to reach $ 66527.18 million by 2028 growing at a CAGR of 11.5% during the forecast period Small molecular drugs, which penetrate through the cell membrane and act on a particular cellular organelle or protein, are employed in targeted drug delivery. Due to their low molecular weight, tiny molecules medications can easily enter cells. Due to their size, simplicity in converting to an oral form, and cost-effectiveness, these molecules perform better than monoclonal antibodies and other large molecular medications.

According to the Centres for Disease Control (CDC), 6 in 10 adults suffer from a chronic condition, such as heart disease, diabetes, cancer, kidney disease, lung disease, or stroke in the US, costing US$ 3.5 trillion to the economy in the US annually for the treatment of these chronic diseases. Chronic diseases are the most significant cause of deaths worldwide, and the number is growing every year.

Key players in the market

Some of the key players profiled in the Small Molecule Drug Discovery Market include 21st Century Therapeutics Inc., Gilead Sciences Inc., BioNTech (4SC-Discovery ), Bristol-Myers Squibb Company, Acacia Pharma Gr, AstraZeneca, Agilent Technologies Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline PLC, Takeda Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc., Merck KGaA, Novartis, Teva Pharmaceuticals Inc.

Key Developments:

In August 2022, BioDuro-Sundia and X-Chem, a DEL technology pioneer in small molecule drug discovery, launched DNA Encoded Compound Library (DEL) technology services in China to help more innovative pharmaceutical companies quickly discover small molecule drugs.

In July 2022, RxCelerate launched RxNfinit. It is a new small molecule discovery platform that leverages machine learning, in silico structure modeling, and combinatorial chemistry in a novel workflow to offer significant advantages over the current generation of tools to identify small molecule drugs against a wide range of protein targets.

Therapeutic Area Covered:
• Oncology
• Central Nervous System
• Cardiovascular
• Respiratory
• Metabolic Disorders
• Gastrointestinal
• Other Therapeutic Areas

Process/Phase Covered:
• Target ID/Validation
• Hit Generation and Selection
• Lead Identification
• Lead Optimizations

End User Covered:
• Pharmaceutical & biotechnology companies
• Academic Institutes

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

❖ レポートの目次 ❖

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Small Molecule Drug Discovery Market, By Therapeutic Area
5.1 Introduction
5.2 Oncology
5.3 Central Nervous System
5.4 Cardiovascular
5.5 Respiratory
5.6 Metabolic Disorders
5.7 Gastrointestinal
5.8 Other Therapeutic Areas
6 Global Small Molecule Drug Discovery Market, By Process/Phase
6.1 Introduction
6.2 Target ID/Validation
6.3 Hit Generation and Selection
6.4 Lead Identification
6.5 Lead Optimization
7 Global Small Molecule Drug Discovery Market, By End User
7.1 Introduction
7.2 Pharmaceutical&biotechnology companies
7.3 Academic Institutes
8 Global Small Molecule Drug Discovery Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 21st Century Therapeutics Inc.
10.2 Gilead Sciences Inc.
10.3 BioNTech (4SC-Discovery )
10.4 Bristol-Myers Squibb Company
10.5 Acacia Pharma Gr
10.6 AstraZeneca
10.7 Agilent Technologies Inc.
10.8 Boehringer Ingelheim GmbH
10.9 GlaxoSmithKline PLC
10.10 Takeda Pharmaceutical Industries Ltd
10.11 Johnson & Johnson
10.12 Pfizer Inc.
10.13 Merck KGaA
10.14 Novartis
10.15 Teva Pharmaceuticals
List of Tables
Table 1 Global Small Molecule Drug Discovery Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
Table 3 Global Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
Table 4 Global Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
Table 5 Global Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 6 Global Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
Table 7 Global Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
Table 8 Global Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
Table 9 Global Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
Table 10 Global Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
Table 11 Global Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
Table 12 Global Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
Table 13 Global Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
Table 14 Global Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
Table 15 Global Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
Table 16 Global Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
Table 17 Global Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
Table 18 North America Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
Table 19 North America Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
Table 20 North America Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
Table 21 North America Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
Table 22 North America Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 23 North America Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
Table 24 North America Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
Table 25 North America Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
Table 26 North America Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
Table 27 North America Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
Table 28 North America Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
Table 29 North America Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
Table 30 North America Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
Table 31 North America Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
Table 32 North America Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
Table 33 North America Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
Table 34 North America Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
Table 35 Europe Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
Table 36 Europe Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
Table 37 Europe Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
Table 38 Europe Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
Table 39 Europe Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 40 Europe Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
Table 41 Europe Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
Table 42 Europe Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
Table 43 Europe Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
Table 44 Europe Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
Table 45 Europe Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
Table 46 Europe Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
Table 47 Europe Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
Table 48 Europe Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
Table 49 Europe Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
Table 50 Europe Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
Table 51 Europe Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
Table 52 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
Table 53 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
Table 54 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
Table 55 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
Table 56 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 57 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
Table 58 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
Table 59 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
Table 60 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
Table 61 Asia Pacific Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
Table 62 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
Table 63 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
Table 64 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
Table 65 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
Table 66 Asia Pacific Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
Table 67 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
Table 68 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
Table 69 South America Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
Table 70 South America Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
Table 71 South America Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
Table 72 South America Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
Table 73 South America Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 74 South America Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
Table 75 South America Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
Table 76 South America Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
Table 77 South America Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
Table 78 South America Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
Table 79 South America Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
Table 80 South America Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
Table 81 South America Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
Table 82 South America Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
Table 83 South America Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
Table 84 South America Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
Table 85 South America Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
Table 86 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
Table 87 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
Table 88 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
Table 89 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
Table 90 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 91 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
Table 92 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
Table 93 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
Table 94 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
Table 95 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
Table 96 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
Table 97 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
Table 98 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
Table 99 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
Table 100 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
Table 101 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
Table 102 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 低分子創薬のグローバル市場（～2027）：腫瘍、中枢神経系、心臓血管、呼吸器、代謝障害、胃腸、その他(Small Molecule Drug Discovery Market Forecasts to 2028 – Global Analysis By Therapeutic Area(Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal and Other Therapeutic Areas), Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization), End User (Pharmaceutical & biotechnology companies and Academic Institutes) and By Geography)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 低分子創薬の世界市場予測（～2027年）
  • 治療用酵素のグローバル市場（～2027）：キチナーゼ、アスパルギナーゼ、その他
  • RNA標的低分子創薬の世界市場2023年～2030年：疾患別、エンドユーザー別、地域別
  • 医薬品再利用の世界市場予測（〜2030年）
  • 創薬サービスの世界市場2023年～2030年：プロセス別、種類別、薬剤タイプ別、治療領域別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆